BLOG / 🇺🇸 United States / index intelligence · · daily

Nasdaq 100 Stocks SEC Filings — May 27, 2026

USA NASDAQ-100

By Gunpowder Editorial ·

4 high priority 25 medium priority 29 total filings analysed

Executive Summary

The May 27, 2026, filing batch for the NASDAQ-100 stream is dominated by routine corporate actions (AGM results, debt offerings, and delayed 13F filings), but two high-conviction themes emerge: a hostile takeover battle in the dry bulk shipping sector and a strategic CEO appointment at a late-stage biotech.

Genco Shipping & Trading is the focal point, with Diana Shipping raising its hostile bid to $24.80/share (a 39% premium) while facing near-zero shareholder tenders (0.0002% of shares), setting up a critical proxy fight at the June 18 AGM. In biotech, Immunic's appointment of a Genentech/Roche veteran as CEO, with a pivotal Phase 3 data readout and potential NDA filing by year-end, presents a high-risk/high-reward catalyst. The remaining filings are largely low-materiality, with eight delayed 13F filings from Kentucky Farm Bureau (2016-2018) offering no current trading insights, and several AGM results showing minor shareholder dissent (6-23% withhold votes) but no material impact. Capital allocation signals are mixed: Apple Hospitality REIT extended a $242.5M buyback, while Murphy USA issued $500M in new 5.875% debt, indicating a refinancing or growth capex need.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 13F · 8-K · DEF 14A · DEFA14A · Schedule 13D

Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from May 26, 2026.

Investment Signals (10)

  • Immunic (IMUX) (BULLISH)
    ▲

    Appointed Erik Lundgren (ex-Genentech/Roche, launched Ocrevus) as CEO effective June 1, 2026, signaling a shift toward commercialization. Pivotal Phase 3 RMS data readout expected by year-end 2026 with potential NDA filing. Pre-revenue with high regulatory risk, but the hire de-risks the commercial pathway.

  • Genco Shipping (GNK)
    ▲

    Diana Shipping's increased hostile bid to $24.80/share (39% premium) is fully financed with $1.433B in committed financing. However, only 38 shares (<0.001% of outstanding) tendered as of May 27, suggesting strong shareholder rejection. Proxy fight at June 18 AGM is the key catalyst. [BULLISH for GNK shareholders holding out for higher bid]

  • Apple Hospitality REIT (APLE) (BULLISH)
    ▲

    Extended share repurchase program through July 2027 with $242.5M authorized, signaling management confidence in intrinsic value. 2025 AGM saw all proposals pass, though director Howard Woolley received 6.2% withhold votes, a minor governance flag.

  • Murphy USA (MUSA)
    ▲

    Issued $500M in 5.875% Senior Notes due 2034, a significant debt raise. The 5.875% coupon is relatively high for an investment-grade credit, suggesting potential stress or aggressive growth financing. Proceeds use not disclosed. [NEUTRAL/BEARISH]

  • Radian Group (RDN) (BULLISH)
    ▲

    Approved 2026 Equity Compensation Plan and granted performance-based BV RSUs with a 200% maximum payout and a Relative TSR Modifier. The three-year performance period (through 2029) aligns management with long-term book value growth.

  • Immunocore (IMCR) (BEARISH)
    ▲

    2026 AGM passed all resolutions, but 22.5% of votes were cast against executive compensation and director Kristine Peterson, indicating significant shareholder discontent. This is a governance red flag that could lead to activist pressure.

  • Richmond Mutual Bancorp (RMBI) (BULLISH)
    ▲

    Shareholders overwhelmingly approved the merger with Farmers Bancorp (6.6M for vs 106K against), a key catalyst for unlocking value. Director Kathryn Girten received 12.9% withhold votes, but the merger approval is the dominant signal.

  • MetaVia (MTVA)
    ▲

    Presented new Phase 1 data on DA-1726 (dual GLP1R/GCGR agonist) at EASL 2026. No quantitative data disclosed, but the late-breaking poster status implies potentially differentiated data in the competitive obesity/NAFLD space. [NEUTRAL/BULLISH]

  • Comcast (CMCSA) (NEUTRAL)
    ▲

    Filed an 8-K referencing a press release but disclosed no financial data. The filing lists numerous debt securities (0.000% to 5.50% coupons), suggesting a routine debt restructuring or remarketing. Low materiality.

  • Kennametal (KMT) (NEUTRAL)
    ▲

    Completed a cash tender offer for its 4.625% Senior Notes due 2028, a liability management move that reduces near-term debt maturities. No financial impact disclosed.

Risk Flags (8)

  • Genco Shipping (GNK) / Hostile Takeover Risk [HIGH RISK]
    ▼

    Diana Shipping's unsolicited tender offer at $24.80/share (39% premium) is fully financed, but only 38 shares tendered. The June 18 AGM proxy fight is binary: if Diana's six director nominees win, the tender offer could be extended, potentially forcing a sale at a lower price.

  • Immunocore (IMCR) / Governance Risk [MEDIUM RISK]
    ▼

    22.5% of votes cast against executive compensation and director Kristine Peterson at the 2026 AGM. This level of dissent is unusually high and may signal deeper board-level issues or compensation misalignment.

  • Murphy USA (MUSA) / Debt Risk [MEDIUM RISK]
    ▼

    Issued $500M in 5.875% Senior Notes due 2034. The 5.875% coupon is elevated, implying below-investment-grade credit metrics or aggressive leverage. If proceeds are used for buybacks rather than growth, it could strain the balance sheet.

  • Immunic (IMUX) / Clinical Risk [HIGH RISK]
    ▼

    The entire investment thesis hinges on the pivotal Phase 3 RMS data readout by year-end 2026. A negative or mixed readout would render the stock worthless, as the company is pre-revenue.

  • Kentucky Farm Bureau / Reporting Lapse Risk↓ [LOW RISK]
    ▼

    Filed eight 13F-HR reports for periods ending between 2016 and 2018, all on May 27, 2026. This is a multi-year delay in reporting, which could indicate internal control failures or regulatory scrutiny. While not a NASDAQ-100 company, it flags a systemic filing issue.

  • Maui Land & Pineapple (MLP) / Governance Risk [LOW RISK]
    ▼

    Director A. Catherine Ngo received 1.2M withheld votes (7.5% of votes cast) at the 2026 annual meeting, the highest among nominees. This is a minor governance flag but not material.

  • Estrella Immunopharma (ESLA) / Inactivity Risk [LOW RISK]
    ▼

    The sole proposal at the June 29, 2026 AGM is to ratify auditors. No directors are being elected, and no business updates are provided. This suggests a dormant or cash-constrained company with limited shareholder engagement.

  • Dime Community Bancshares (DCOM) / Low Disclosure Risk [LOW RISK]
    ▼

    Filed an 8-K stating a presentation was made available at the Annual Meeting but provided no financial figures. This lack of transparency is a minor concern for a bank holding company.

Opportunities (8)

  • Genco Shipping (GNK) / Hostile Bid Arbitrage (OPPORTUNITY)
    ◆

    Diana Shipping's $24.80/share bid represents a 39% premium, but with only 38 shares tendered, the market expects a higher bid or a white knight. The June 18 AGM proxy fight is the catalyst. If Diana's nominees win, the offer could be extended, but if Genco's board prevails, a higher bid is likely.

  • Immunic (IMUX) / CEO Catalyst (OPPORTUNITY)
    ◆

    The appointment of Erik Lundgren, a Genentech/Roche veteran who helped launch Ocrevus ($6B+ peak sales), is a strong signal of commercial readiness. The pivotal Phase 3 RMS data readout by year-end 2026 is a binary catalyst. Pre-revenue biotech with high risk/reward.

  • Apple Hospitality REIT (APLE) / Buyback Opportunity (OPPORTUNITY)
    ◆

    The extension of the $242.5M share repurchase program through July 2027 provides a floor for the stock. With a 5.5% dividend yield and a hotel REIT recovery underway, the buyback adds a catalyst.

  • Richmond Mutual Bancorp (RMBI) / Merger Arbitrage (OPPORTUNITY)
    ◆

    Shareholders approved the merger with Farmers Bancorp, creating a combined entity with enhanced scale. The deal spread may still offer a small arbitrage opportunity if the closing is on track.

  • MetaVia (MTVA) / Obesity Catalyst (OPPORTUNITY)
    ◆

    The late-breaking Phase 1 data on DA-1726 at EASL 2026 could show differentiation in the GLP-1/glucagon agonist space. If the data shows superior efficacy or tolerability, MTVA could be a takeout target.

  • Radian Group (RDN) / Long-Term Incentive Alignment (OPPORTUNITY)
    ◆

    The new performance-based BV RSUs with a 200% maximum payout and Relative TSR Modifier strongly align management with shareholder value creation over three years. This is a positive signal for long-term holders.

  • NCS Multistage (NCSM) / Strong Shareholder Support (OPPORTUNITY)
    ◆

    84.9% of eligible votes were cast at the AGM, and all proposals passed with >92% support. This indicates strong retail/institutional confidence in the board's strategy.

  • Artificial Intelligence Technology Solutions (AITX) / Pilot Conversion (OPPORTUNITY)
    ◆

    Subsidiary RAD converted a retail security pilot into a long-term deployment. While no financial details were disclosed, this is a positive signal for recurring revenue growth in the AI security space.

Sector Themes (6)

  • Hostile Takeover Activity in Shipping
    ◆

    The Genco Shipping/Diana Shipping battle highlights a trend of consolidation in the dry bulk sector, driven by low valuations and fragmented ownership. The 39% premium and fully committed financing suggest Diana is serious, but shareholder resistance is high. Watch for similar moves in other shipping names.

  • Biotech CEO Appointments Signal Commercial Readiness
    ◆

    Immunic's hire of a Genentech/Roche commercial executive (Erik Lundgren) mirrors a broader trend of late-stage biotechs recruiting Big Pharma commercial talent ahead of pivotal data readouts. This pattern often precedes M&A or significant stock moves.

  • Debt Issuance for Growth vs. Refinancing
    ◆

    Murphy USA's $500M 5.875% note issuance contrasts with Kennametal's tender offer to retire 4.625% notes. This divergence suggests some companies are locking in higher rates for growth, while others are de-levering. Watch for credit rating impacts.

  • Shareholder Dissent on Compensation Rising
    ◆

    Immunocore (22.5% against) and Richmond Mutual (12.9% against a director) show elevated dissent on compensation and director elections. This is a broader governance trend that could lead to say-on-pay failures or activist campaigns.

  • Delayed 13F Filings: A Systemic Issue?
    ◆

    Kentucky Farm Bureau's batch filing of eight 13F reports (2016-2018) on the same day is highly unusual. While not a NASDAQ-100 issue, it raises questions about the timeliness of institutional ownership data and potential SEC scrutiny.

  • AGM Season: Routine but with Governance Nuances
    ◆

    The majority of filings (8 of 29) are AGM results, with most passing smoothly. However, the presence of 6-12% withhold votes at several companies (Apple Hospitality, Immunocore, Maui Land) suggests that governance is becoming a more active shareholder concern.

Watch List (8)

  • Genco Shipping (GNK) / June 18 AGM
    👁

    The proxy fight with Diana Shipping is the key catalyst. Watch for additional tender offers, white knight bids, or shareholder voting results. The outcome will determine the stock's direction.

  • Immunic (IMUX) / Phase 3 RMS Data Readout
    👁

    CEO transition complete; watch for Phase 3 data timing (expected year-end 2026). Any data updates or regulatory interactions will be highly material.

  • Murphy USA (MUSA) / Debt Proceeds Use
    👁

    The $500M note issuance is a large debt raise. Watch for disclosure of proceeds use (buybacks, capex, M&A) in the next earnings call. If used for buybacks, it could be positive; if for M&A, it could signal a transformation.

  • Immunocore (IMCR) / Shareholder Activism
    👁

    With 22.5% dissent on compensation and director elections, watch for activist filings or further engagement from large shareholders. The next AGM or investor day could see changes.

  • Apple Hospitality REIT (APLE) / Buyback Execution
    👁

    The $242.5M buyback authorization is large relative to market cap (~$3.5B). Watch for actual repurchase activity in the next 10-Q to gauge management's conviction.

  • MetaVia (MTVA) / EASL 2026 Data Readout
    👁

    The late-breaking poster at EASL 2026 (May 27-30) may yield detailed Phase 1 data. Watch for analyst notes or press releases with quantitative efficacy/safety data.

  • Richmond Mutual Bancorp (RMBI) / Merger Close
    👁

    The merger with Farmers Bancorp was approved. Watch for regulatory approvals and closing timeline. Any delays could widen the arbitrage spread.

  • Kentucky Farm Bureau / SEC Scrutiny↓
    👁

    The batch filing of eight delayed 13F reports is a red flag. Watch for any SEC comment letters or enforcement actions, which could have implications for other late filers.

Filing Analyses (29)
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ended December 31, 2016, reporting a total of 82 equity holdings with an aggregate market value of approximately $178.6 million. The portfolio is diversified across sectors, with top holdings including SPDR Trust ($23.0M), PowerShares QQQ ($14.6M), and UnitedHealth Group ($3.7M). No period-over-period comparisons are available as this is a single-period filing.

  • · The filing was signed by Jena B. Stone, Vice President, Accounting & Finance, on May 27, 2026.
  • · All 82 positions are held with sole voting and dispositive power; no shared or non-dispositive holdings are reported.
  • · The largest single equity position is SPDR Trust (SPY) with 103,000 shares valued at $23,023,590.
  • · The second largest position is PowerShares QQQ Trust with 123,000 shares valued at $14,573,040.
  • · Other significant positions include UnitedHealth Group (23,000 shares, $3,680,920), Chevron (30,000 shares, $3,531,000), and Visa (40,000 shares, $3,120,800).
  • · The portfolio includes sector-specific ETFs such as Technology Select Sector SPDR (50,000 shares, $2,418,000) and Financial Select Sector SPDR (50,000 shares, $1,162,500).
  • · The filing covers the period ended December 31, 2016, but was submitted on May 27, 2026, indicating a significant delay in reporting.
Artificial Intelligence Technology Solutions Inc. 8-K neutral materiality 3/10

27-05-2026

AITX announced that its subsidiary RAD has converted a retail security pilot into a long-term deployment, as disclosed in a press release issued on May 27, 2026. The filing provides no financial details, quantitative metrics, or period-over-period comparisons, limiting the ability to assess material impact.

  • · The filing is an 8-K under Items 8.01 and 9.01, with the press release attached as Exhibit 99.1.
  • · No financial figures, revenue impact, or deployment scale were disclosed.
  • · The press release is furnished (not filed) under the Exchange Act, limiting liability.
IMMUNIC, INC. 8-K positive materiality 8/10

27-05-2026

Immunic appointed Erik Lundgren as CEO effective June 1, 2026, succeeding Daniel Vitt who remains on the Board and retains scientific strategy responsibilities. Lundgren brings deep MS commercial expertise from Genentech/Roche, including helping launch Ocrevus, to lead Immunic toward commercialization of vidofludimus calcium. The company is preparing for a pivotal Phase 3 RMS data readout by year-end 2026 and potential NDA filing, but remains a pre-revenue late-stage biotech with inherent regulatory and financial risks.

  • · Erik Lundgren holds a BA from Duke University and an MBA from Harvard Business School.
  • · He most recently served as SVP Commercial Portfolio Organization at Genentech, overseeing all therapeutic area commercial strategies.
  • · He previously served as General Manager of Roche Czech Republic and Lifecycle Leader for Huntington's disease at Roche.
  • · Lundgren's initial equity option is for 1,000,000 shares under the 2026 Inducement Equity Compensation Plan, vesting 25% on the one-year anniversary of May 22, 2026 and the remainder monthly over 36 months.
  • · The company's pipeline also includes IMU-856 and IMU-381 for neurodegenerative, chronic inflammatory, and autoimmune diseases.
  • · The filing includes forward-looking statement cautionary language referencing risk factors in the 2025 10-K filed February 26, 2026.
Apple Hospitality REIT, Inc. 8-K neutral materiality 5/10

27-05-2026

Apple Hospitality REIT held its 2025 Annual Meeting on May 22, 2026, where shareholders elected all eight director nominees, ratified KPMG LLP as independent auditor for 2026, and approved executive compensation in a non-binding advisory vote. The Board also extended the existing share repurchase program through July 2027, authorizing up to $242.5 million in common share repurchases. While all proposals passed, director Howard E. Woolley received a notable 11.3 million withhold votes (6.2% of votes cast), indicating some shareholder dissent.

  • · All eight director nominees were elected with substantial majorities; the highest vote total was Carolyn B. Handlon with 180,820,187 for votes.
  • · The ratification of KPMG LLP as independent auditor passed with 199,438,485 for votes and only 2,704,182 against.
  • · The advisory vote on executive compensation passed with 175,328,993 for, 5,940,374 against, and 730,287 abstentions.
  • · The share repurchase program extension was approved by the Board on May 22, 2026, and extends through July 2027.
  • · Repurchases under the program may be made in open market, through 10b5-1 plans, or privately negotiated transactions.
RADIAN GROUP INC 8-K neutral materiality 5/10

27-05-2026

Radian Group Inc. stockholders approved the 2026 Equity Compensation Plan on May 21, 2026, and the Compensation Committee granted annual long-term incentive awards (2026 LTI Awards) to named executive officers, comprising performance-based BV RSUs and time-based RSUs. The company also approved new executive severance agreements for several officers, with modified definitions of 'Good Reason' and equity vesting provisions, while noting the retirement of Senior EVP Eric Ray. No financial performance metrics were disclosed in this filing.

  • · The 2026 Equity Compensation Plan was approved by stockholders on May 21, 2026.
  • · BV RSUs vest on May 25, 2029, with performance measured by cumulative growth in LTI Book Value per Share over a three-year period, adjusted by a Relative TSR Modifier.
  • · Maximum BV RSU payout is 200% of target; threshold performance (≤20% growth) yields 0% payout.
  • · Relative TSR Modifier can increase payout by +25% (≥90th percentile) or decrease by -25% (≤10th percentile), but if Company Absolute TSR is negative, modifier cannot exceed 'no modifier'.
  • · Time-Based RSUs vest in three equal annual installments on May 25, 2027, 2028, and 2029.
  • · New executive severance agreements were approved for Ms. Bartholomew and Messrs. Keleher, Kobell, and Watson; amended agreements for Ms. Dickerson and Messrs. Hoffman and Quigley.
  • · Eric Ray (Chief Digital Officer) previously announced his intention to retire.
  • · A new CEO will be appointed effective August 13, 2026; the current CEO is subject to an employment agreement.
Immunocore Holdings plc 8-K mixed materiality 5/10

27-05-2026

Immunocore Holdings plc held its 2026 Annual General Meeting on May 27, 2026, where all ten resolutions were passed. While most resolutions received overwhelming support (e.g., re-appointment of directors Siddharth Kaul and William Pao with over 99% for votes), the advisory vote on named executive officer compensation and the re-appointment of director Kristine Peterson each saw significant opposition, with approximately 22.5% of votes cast against. The directors' remuneration report also faced notable dissent, with 22.8% against.

  • · The AGM was held on May 27, 2026, and all ten resolutions were passed.
  • · Resolution 9 (directors' remuneration report) had the highest number of abstentions at 85,575 votes.
  • · Resolution 5 (ratification of Deloitte as U.S. auditor) had the highest support percentage, with only 984 votes against.
  • · Resolution 10 (political donations authorization) had the lowest number of against votes at 82,113.
  • · The proxy statement was filed on April 16, 2026.
NCS Multistage Holdings, Inc. 8-K positive materiality 3/10

27-05-2026

NCS Multistage Holdings, Inc. held its 2026 Annual Meeting on May 27, 2026, with 84.9% of eligible votes cast. Stockholders elected two Class III directors (John Deane and W. Matt Ralls), ratified Grant Thornton LLP as independent auditor for 2026, and approved advisory say-on-pay compensation. All proposals passed with strong support, though director John Deane received a relatively lower 'for' vote percentage (92.7%) compared to W. Matt Ralls (95.7%).

  • · John Deane received 1,800,311 votes 'for' and 142,468 'withheld' (92.7% for).
  • · W. Matt Ralls received 1,858,268 votes 'for' and 84,511 'withheld' (95.7% for).
  • · Ratification of Grant Thornton LLP passed with 2,226,925 'for', 849 'against', and 933 abstentions.
  • · Advisory say-on-pay passed with 1,938,033 'for', 3,111 'against', and 1,635 abstentions.
  • · Broker non-votes totaled 285,928 for director election and say-on-pay proposals.
Murphy USA Inc. 8-K neutral materiality 6/10

27-05-2026

Murphy USA Inc. announced the issuance of $500,000,000 aggregate principal amount of 5.875% Senior Notes due 2034 by its subsidiary Murphy Oil USA, with Murphy USA and other guarantors providing guarantees. The notes bear interest at 5.875% per annum, mature on June 1, 2034, and include customary covenants and redemption provisions. The offering was conducted under Rule 144A and Regulation S, and the notes are not registered under the Securities Act.

  • · Interest on the 2034 Notes is payable semi-annually on June 1 and December 1, beginning December 1, 2026.
  • · The notes may be redeemed at any time on or after June 1, 2029 at specified redemption prices, or prior to that date at a 'make whole' redemption price.
  • · Up to 40% of the notes can be redeemed with net cash proceeds from certain equity offerings before June 1, 2029, provided at least 60% remains outstanding and redemption occurs within 90 days of the equity offering.
  • · Most restrictive covenants will be suspended if the notes receive investment grade ratings from any two of S&P, Moody's, and Fitch, and no default is continuing.
  • · The notes were sold only to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S, and are not registered under the Securities Act.
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ending September 30, 2016, reporting a portfolio of 82 equity holdings with a total market value of approximately $179.3 million. The filing shows a diversified portfolio weighted toward large-cap U.S. equities and ETFs, with top holdings including SPDR S&P 500 ETF ($23.1M), PowerShares QQQ Trust ($15.4M), and Visa Inc. ($3.8M). No period-over-period comparisons are available as this is a single-period filing.

  • · The portfolio includes 82 equity positions with a total market value of $179,323,163 as of September 30, 2016.
  • · The top 10 holdings by market value are: SPDR S&P 500 ETF ($23.1M), PowerShares QQQ Trust ($15.4M), Visa Inc. ($3.8M), Johnson & Johnson ($3.5M), UnitedHealth Group ($3.2M), Chevron Corp ($3.1M), AutoZone Inc ($3.1M), Procter & Gamble ($2.9M), Churchill Downs Inc ($2.9M), and Lockheed Martin Corp ($2.7M).
  • · The portfolio is heavily weighted toward ETFs, with the two largest positions (SPY and QQQ) representing 21.5% of total value.
  • · All holdings are listed with sole voting and investment authority, indicating direct control over all positions.
  • · The filing was signed by Jena B. Stone, Vice President, Accounting & Finance, on May 27, 2026, for the period ended September 30, 2016.
KENNAMETAL INC 8-K neutral materiality 4/10

27-05-2026

Kennametal Inc. filed an 8-K on May 27, 2026, announcing the pricing terms and final results of a cash tender offer to purchase any and all of its 4.625% Senior Notes due 2028. The tender offer expired on May 26, 2026, and the company issued two press releases detailing the pricing and final results. No financial figures or performance metrics were disclosed in this filing.

  • · The tender offer was for any and all of the company's 4.625% Senior Notes due 2028.
  • · The tender offer expired on May 26, 2026.
  • · Two press releases were issued: one on May 26, 2026 (pricing terms) and one on May 27, 2026 (final results and expiration).
  • · The filing does not include any financial results or performance data.
Dime Community Bancshares, Inc. /NY/ 8-K neutral materiality 2/10

27-05-2026

Dime Community Bancshares, Inc. disclosed on May 27, 2026, that it made a financial presentation available to investors for its Annual Meeting of Shareholders. The presentation is accessible on the company's website. No specific financial figures or performance metrics were provided in this filing.

  • · The presentation is available on the company's website at www.dime.com under Investor Relations > Presentations.
  • · The information is furnished and not deemed filed under the Exchange Act.
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ended December 31, 2018, reporting total holdings of approximately $204.5 million across 84 equity positions. The portfolio is heavily weighted toward large-cap U.S. equities and ETFs, with top holdings including SPDR S&P 500 ETF ($27.0M), Invesco QQQ Trust ($19.0M), and individual names such as Boeing ($3.9M), UnitedHealth Group ($4.2M), and Visa ($4.6M). The filing reflects a diversified, income-oriented strategy with significant exposure to technology, financials, and consumer staples.

  • · The filing was submitted on May 27, 2026, covering the period ended December 31, 2018, indicating a significant delay in reporting.
  • · All 84 positions are held with sole voting and dispositive power; no shared or non-dispositive holdings are reported.
  • · The largest single equity holding is Visa Inc. at $4.6M (35,000 shares), followed by UnitedHealth Group at $4.2M (17,000 shares) and Boeing at $3.9M (12,000 shares).
  • · ETF holdings are substantial: SPDR S&P 500 ETF ($27.0M), Invesco QQQ Trust ($19.0M), and Vanguard FTSE Developed Markets ETF ($2.8M).
  • · The portfolio includes a mix of growth (Apple, Amazon, Microsoft) and defensive (Procter & Gamble, Coca-Cola, Duke Energy) names.
  • · No period-over-period comparisons are available as this is a single-period filing.
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ending June 30, 2018, reporting total holdings of approximately $214.7 million across 82 equity positions. The portfolio is heavily weighted toward large-cap U.S. equities and ETFs, with top holdings including SPDR Trust ($27.1M), Invesco QQQ Trust ($21.1M), and Technology Select Sector SPDR ($4.2M). The filing reflects a diversified, income-oriented strategy with significant exposure to technology, financials, and utilities, but no period-over-period comparison is available as this is a snapshot filing.

  • · The filing was signed by Jena B. Stone, Vice President, Accounting & Finance, on May 27, 2026.
  • · All 82 positions are held with sole voting and dispositive power; no shared or no-power holdings are reported.
  • · The portfolio includes 10 ETFs/trusts, representing a significant allocation to passive strategies.
  • · Notable holdings include Apple Inc ($3.7M), Boeing ($4.0M), Chevron ($3.2M), and UnitedHealth Group ($4.2M).
  • · International exposure is limited to ADRs (Alibaba) and foreign-domiciled stocks (Medtronic, Willis Towers Watson).
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ending June 30, 2016, reporting a total portfolio value of approximately $182.8 million across 84 equity holdings. The largest positions include SPDR Trust ($24.1M), PowerShares QQQ ($14.0M), and Johnson & Johnson ($3.6M), with a diversified mix of large-cap U.S. stocks and ETFs. No period-over-period comparisons are available as this is a single filing.

  • · The filing was signed by Jena B. Stone, Vice President, Accounting & Finance, on May 27, 2026.
  • · All 84 holdings are listed with sole voting and dispositive power, indicating direct control over all positions.
  • · The portfolio includes a mix of common stocks and ETFs, with significant exposure to technology (Apple, Microsoft, Facebook), healthcare (Johnson & Johnson, Merck, Amgen), and consumer staples (Procter & Gamble, Coca-Cola, PepsiCo).
  • · Notable smaller positions include Valeant Pharmaceuticals ($161,120) and Tableau Software ($489,200).
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its Form 13F-HR for the quarter ended March 31, 2018, reporting total holdings of approximately $209.7 million across 82 equity positions. The portfolio is heavily weighted toward large-cap U.S. equities and ETFs, with top holdings including SPDR S&P 500 ETF ($26.3M), Invesco QQQ Trust ($19.7M), and UnitedHealth Group ($4.3M). No period-over-period comparisons are available as this is a single-period filing.

  • · The filing covers the quarter ended March 31, 2018, and was submitted on May 27, 2026.
  • · The largest single holding is SPDR S&P 500 ETF Trust (100,000 shares, $26.3M), followed by Invesco QQQ Trust (123,000 shares, $19.7M).
  • · Other significant positions include UnitedHealth Group (20,000 shares, $4.3M), Boeing (14,000 shares, $4.6M), and Lockheed Martin (11,114 shares, $3.8M).
  • · The portfolio includes sector-specific ETFs: Technology Select Sector SPDR ($3.9M), Financial Select Sector SPDR ($2.2M), and Energy Select Sector SPDR ($1.3M).
  • · International exposure is provided via Vanguard FTSE Developed Markets ETF ($3.3M), Vanguard FTSE Emerging Markets ETF ($2.6M), and Vanguard FTSE Europe ETF ($2.3M).
  • · Valvoline Inc is listed with zero shares and zero value, likely a residual or eliminated position.
  • · All 82 positions are held with sole voting and dispositive power; no shared or non-dispositive authority is reported.
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the quarter ended March 31, 2016, reporting a total portfolio value of approximately $179.5 million across 84 holdings. The largest positions include SPDR Trust ($22.6M), PowerShares QQQ ($14.2M), and Visa Inc. ($3.6M). The filing reflects a diversified equity portfolio with a focus on large-cap U.S. stocks.

  • · The filing is for the quarter ended March 31, 2016, filed on May 27, 2026.
  • · The portfolio consists of 84 holdings with a total value of $179,509,911.
  • · Top holdings by value: SPDR Trust ($22,607,200), PowerShares QQQ ($14,196,000), Visa Inc. ($3,594,560), Nike Inc. ($3,073,500), Lowe's Cos Inc ($3,030,000), Home Depot ($3,068,890), Johnson & Johnson ($3,246,000), UnitedHealth Group ($2,964,700), Churchill Downs Inc ($2,957,600), Apple Inc ($2,833,740).
  • · The portfolio includes a mix of common stocks and ETFs, with no options or other derivatives reported.
  • · All holdings are listed as sole voting and dispositive power.
Richmond Mutual Bancorporation, Inc. 8-K positive materiality 8/10

27-05-2026

Richmond Mutual Bancorporation, Inc. (RMBI) held its Annual Meeting on May 27, 2026, where stockholders approved all five proposals, including the merger with Farmers Bancorp (Frankfort, Indiana) and the issuance of shares. The merger proposal received overwhelming support with 6,608,986 votes for and only 106,010 against, while the advisory vote on executive compensation also passed with 6,161,703 votes for. However, director Kathryn Girten received a notable 863,988 withheld votes (12.9% of votes cast), indicating some shareholder dissent.

  • · The merger agreement was dated November 11, 2025.
  • · The record date for voting was March 23, 2026.
  • · Broker non-votes totaled 1,668,371 on all proposals except the auditor ratification (which had no broker non-votes).
  • · The adjournment proposal was approved but not needed as the merger proposal passed.
  • · The annual meeting was held on May 27, 2026.
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 3/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ended December 31, 2017, reporting a total portfolio value of approximately $209.0 million across 79 equity holdings. The filing shows a diversified portfolio with top holdings in SPDR Trust (10.0% of portfolio), PowerShares QQQ (9.2%), and Technology Select Sector SPDR (1.8%). The portfolio is heavily weighted toward U.S. large-cap equities and ETFs, with no prior-period comparison available in this filing.

  • · Top 5 holdings by value: SPDR Trust ($26.7M), PowerShares QQQ ($19.2M), Technology Select Sector SPDR ($3.8M), Visa Inc ($4.0M), UnitedHealth Group ($4.4M).
  • · Largest single equity position: UnitedHealth Group at $4.4M (20,000 shares).
  • · Portfolio includes 10 ETFs/ETPs totaling approximately $47.6M (22.8% of portfolio).
  • · No options or convertible securities reported; all positions are common stock or ETF shares.
  • · Filing is for period ended December 31, 2017, but submitted on May 27, 2026 (over 8 years late).
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ending September 30, 2018, reporting 82 equity holdings with a total market value of approximately $199.2 million. The portfolio is diversified across sectors with top holdings including Invesco QQQ Trust ($20.1M), Apple ($4.5M), and Technology Select Sector SPDR ($4.5M). The filing reflects a conservative, income-oriented strategy with significant exposure to utilities, consumer staples, and large-cap technology.

  • · The largest single holding is Invesco QQQ Trust at $20,065,320 (108,000 shares), representing about 10% of the portfolio.
  • · Top 10 holdings by value: Invesco QQQ Trust ($20.1M), Apple ($4.5M), Technology Select Sector SPDR ($4.5M), UnitedHealth Group ($4.5M), Thermo Fisher Scientific ($4.1M), Visa ($5.3M), JP Morgan Chase ($3.6M), Lockheed Martin ($3.5M), Johnson & Johnson ($3.5M), Union Pacific ($3.4M).
  • · The portfolio includes 15 ETFs/SPDRs, indicating significant use of passive investment vehicles.
  • · Sector exposure includes technology (QQQ, XLK, IYW), utilities (IDU, Duke, Vectren), financials (XLF, KRE, JPM, PNC, USB, WFC), and consumer staples (KO, PEP, PG, K, YUM).
  • · No period-over-period comparisons are available as this is a single-period filing.
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ended September 30, 2017, reporting a diversified equity portfolio of 81 holdings valued at approximately $199.3 million. The largest positions include SPDR Trust ($25.1M), PowerShares QQQ ($17.9M), and UnitedHealth Group ($3.9M). The filing reflects a conservative, income-oriented strategy with significant exposure to large-cap U.S. equities and sector ETFs.

  • · The filing is for the period ended September 30, 2017, but was filed on May 27, 2026.
  • · The portfolio includes 81 equity positions with a total market value of $199,302,914.
  • · Top holdings by value: SPDR Trust ($25.1M, 100,000 shares), PowerShares QQQ ($17.9M, 123,000 shares), UnitedHealth Group ($3.9M, 20,000 shares), Visa Inc. ($3.7M, 35,000 shares), Boeing ($3.6M, 14,000 shares).
  • · The portfolio has significant sector ETF exposure: Technology Select Sector SPDR ($3.5M), Financial Select Sector SPDR ($1.6M), Energy Select Sector SPDR ($1.4M), Materials Select Sector SPDR ($1.5M), SPDR S&P Regional Banking ETF ($2.0M), SPDR S&P 500 Oil & Gas Exp ($0.9M).
  • · International exposure via Vanguard FTSE Dev Mkts ETF ($2.4M), Vanguard FTSE Emerging Mkts ETF ($2.0M), and Vanguard FTSE Europe ETF ($2.3M).
  • · The filer is a mutual insurance company based in Louisville, Kentucky.
  • · No period-over-period comparisons are available as this is a single-period filing.
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ended June 30, 2017, reporting a total portfolio value of approximately $195.6 million across 82 equity holdings. The largest positions include SPDR Trust ($24.2M), PowerShares QQQ ($16.9M), and UnitedHealth Group ($4.3M), indicating a diversified portfolio with significant exposure to large-cap U.S. equities and sector ETFs. No prior period comparison is available in this filing, so performance trends cannot be assessed.

  • · Top 5 holdings by value: SPDR Trust ($24.2M), PowerShares QQQ ($16.9M), Technology Select Sector SPDR ($3.3M), UnitedHealth Group ($4.3M), Visa Inc ($3.8M).
  • · Largest single equity position: UnitedHealth Group Inc with 23,000 shares valued at $4,264,660.
  • · Portfolio includes 82 positions with no single stock exceeding 2.2% of total value, indicating broad diversification.
  • · Sector ETFs (Technology, Financial, Energy, Materials, Utilities, Realty) collectively represent a significant allocation.
  • · No prior period comparison data is available in this filing.
Kentucky Farm Bureau Mutual Insurance Co 13F-HR neutral materiality 5/10

27-05-2026

Kentucky Farm Bureau Mutual Insurance Co filed its 13F-HR for the period ended March 31, 2017, reporting a total portfolio value of approximately $191.5 million across 83 equity holdings. The largest positions include SPDR Trust ($23.6M), PowerShares QQQ ($16.3M), and UnitedHealth Group ($3.8M). The filing reflects a diversified portfolio with significant exposure to large-cap U.S. equities and sector ETFs.

  • · The filing was signed by Jena B. Stone, Vice President, Accounting & Finance, on May 27, 2026.
  • · All 83 positions are held with sole voting and dispositive power; no shared or non-dispositive holdings are reported.
  • · The portfolio includes 11 sector/regional ETFs, with the largest ETF position being SPDR Trust at $23.6M.
  • · Notable holdings include Apple ($2.9M), Microsoft ($1.6M), and Amazon (not listed).
  • · The filing covers the quarter ended March 31, 2017, but was submitted on May 27, 2026, indicating a significant delay.
MAUI LAND & PINEAPPLE CO INC 8-K positive materiality 3/10

27-05-2026

Maui Land & Pineapple Company held its 2026 annual meeting on May 27, 2026. Stockholders elected seven director nominees, approved executive compensation on an advisory basis, and ratified Accuity LLP as independent auditor for fiscal year 2026. All proposals passed with strong support, though there were notable withhold votes for some directors.

  • · Director John Sabin received the most votes for (14,905,935) and fewest withheld (33,469).
  • · Director A. Catherine Ngo had the highest withheld votes (1,213,590) among nominees.
  • · Proposal 2 (say-on-pay) had 14,604,008 for, 372,648 against, and 24,032 abstentions.
  • · Proposal 3 (auditor ratification) passed with 18,261,724 for, 22,681 against, and 5,783 abstentions.
  • · Broker non-votes were 3,289,500 for Proposals 1 and 2, and 0 for Proposal 3.
GENCO SHIPPING & TRADING LTD SC 14D9/A neutral materiality 5/10

27-05-2026

Genco Shipping & Trading Ltd filed an amended solicitation/recommendation statement (SC 14D9/A) on May 27, 2026, in connection with a tender offer. The filing includes forward-looking statements regarding dividend payments, which are subject to various factors including credit agreement limitations, Marshall Islands law, and Board discretion. The company also reminds shareholders of its definitive proxy statement for the 2026 Annual Meeting and encourages voting using the WHITE proxy card.

  • · The filing is an amendment (SC 14D9/A) to a prior Schedule 14D-9 solicitation/recommendation statement.
  • · Dividend payments depend on credit agreement restrictions, Marshall Islands law, and quarterly Board review of financial performance and market developments.
  • · The company has filed a definitive proxy statement for the 2026 Annual Meeting and is soliciting proxies via a WHITE proxy card.
  • · Shareholders can obtain free copies of SEC filings from www.sec.gov or the company's investor relations website.
Estrella Immunopharma, Inc. DEF 14A neutral materiality 3/10

27-05-2026

Estrella Immunopharma, Inc. filed a definitive proxy statement (DEF 14A) for its Combined 2025/2026 Annual Meeting of Stockholders to be held virtually on June 29, 2026. The sole proposal is to ratify the appointment of Macias Gini & O’Connell LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026. No directors are being elected as there are no Class I directors on the board.

  • · The annual meeting will be held virtually on June 29, 2026 at 10:00 a.m. Eastern Time.
  • · Record date for voting is May 20, 2026.
  • · Proxy materials are being distributed on or about May 27, 2026.
  • · Stockholders may vote by mail, Internet, telephone, or live during the virtual meeting.
  • · The meeting serves as the annual meeting for both fiscal year 2025 and fiscal year 2026.
  • · No Class I directors are on the board, so no director elections are scheduled.
GENCO SHIPPING & TRADING LTD DEFA14A neutral materiality 6/10

27-05-2026

Genco Shipping & Trading Ltd filed an additional proxy statement (DEFA14A) on May 27, 2026, in connection with its 2026 Annual Meeting of Shareholders and in response to Diana Shipping Inc.'s unsolicited tender offer. The filing reiterates that dividend payments are subject to Board discretion, credit agreement limitations, Marshall Islands law, and other factors, and that the amount of dividends actually paid may vary. The Company has filed a Schedule 14D-9 solicitation/recommendation statement and a definitive proxy statement on Schedule 14A with a WHITE proxy card, and strongly encourages shareholders to read these documents.

  • · The filing is in response to Diana Shipping Inc.'s unsolicited tender offer.
  • · The Company has filed a Schedule 14D-9 solicitation/recommendation statement with the SEC.
  • · The definitive proxy statement on Schedule 14A was filed on May 7, 2026.
  • · Participants in the proxy solicitation include independent directors and executive officers.
  • · Dividend payments are subject to Board discretion, credit agreement limitations, Marshall Islands law, and other factors.
  • · The Company disclaims any obligation to update forward-looking statements except as required by federal securities laws.
GENCO SHIPPING & TRADING LTD SC 13D/A mixed materiality 9/10

27-05-2026

Diana Shipping Inc. increased its all-cash tender offer to acquire all outstanding shares of Genco Shipping & Trading Ltd to $24.80 per share (from $23.50) and extended the expiration date to June 26, 2026. The increased offer represents a 39% premium to Genco's undisturbed closing price and is fully financed with $1.433 billion in committed financing. However, as of May 27, 2026, only 38 shares (less than 1% of outstanding) had been validly tendered, indicating very low shareholder acceptance to date.

  • · The tender offer was originally scheduled to expire June 2, 2026, now extended to June 26, 2026.
  • · Diana has nominated six independent director candidates for Genco's 2026 Annual Meeting on June 18, 2026.
  • · If Diana's nominees are elected, Diana would be open to further extending the tender offer to allow new directors to engage.
  • · Diana's offer is fully financed with no financing condition.
  • · Genco's share price could decline to approximately $18.00 per share if the offer is not completed and the stock reverts to historical trading levels.
  • · The offer price will be reduced by the amount of any cash dividend or distribution declared by Genco with a record date prior to Diana's purchase of shares.
  • · Diana has delivered a draft merger agreement to Genco's Board that it believes can be finalized in a matter of days.
COMCAST CORP 8-K neutral materiality 2/10

27-05-2026

Comcast Corporation filed a Form 8-K on May 27, 2026, to announce a press release (Exhibit 99.1) issued the same day. The filing does not contain any financial results or quantitative data, and no period-over-period comparisons are provided. The event appears to be a routine disclosure with no material financial impact disclosed.

  • · The filing references multiple debt securities listed on Nasdaq and NYSE, including 0.000% Notes due 2026, 0.250% Notes due 2027, 1.500% Notes due 2029, 0.250% Notes due 2029, 0.750% Notes due 2032, 3.250% Notes due 2032, 1.875% Notes due 2036, 3.550% Notes due 2036, 1.250% Notes due 2040, 5.250% Notes due 2040, 5.50% Notes due 2029, and 2.0% Exchangeable Subordinated Debentures due 2029.
  • · The press release is incorporated by reference but its content is not included in the filing.
MetaVia Inc. 8-K neutral materiality 5/10

27-05-2026

MetaVia Inc. announced the presentation of new Phase 1 data on DA-1726, a novel dual oxyntomodulin (OXM) analog agonist targeting GLP1R and GCGR, at the EASL 2026 Congress in Barcelona. The data was presented as a late-breaking poster on May 27, 2026. No specific financial or quantitative results from the Phase 1 study were disclosed in the filing.

  • · The presentation was a late-breaking poster at EASL 2026, held May 27–30 in Barcelona, Spain.
  • · DA-1726 is a novel dual oxyntomodulin (OXM) analog agonist targeting glucagon-like peptide-1 receptors (GLP1R) and glucagon receptors (GCGR).
  • · The press release is attached as Exhibit 99.1 to the Form 8-K and is incorporated by reference.
  • · The information is furnished under Regulation FD and is not deemed filed for purposes of Section 18 of the Exchange Act.

Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 29 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Nasdaq 100 Stocks SEC Filings

May 22, 2026

Nasdaq 100 Stocks SEC Filings — May 22, 2026

May 21, 2026

Nasdaq 100 Stocks SEC Filings — May 21, 2026

May 20, 2026

Nasdaq 100 Stocks SEC Filings — May 20, 2026

May 19, 2026

Nasdaq 100 Stocks SEC Filings — May 19, 2026

🇺🇸 More from United States

View all →

May 28, 2026

US Pre-Market SEC Filings Roundup — May 28, 2026

US Pre-Market SEC Filings Roundup

May 28, 2026

Dow Jones 30 Stocks SEC Filings — May 28, 2026

Dow Jones 30 Stocks SEC Filings

May 28, 2026

US Merger & Acquisition SEC Filings — May 28, 2026

US Merger & Acquisition SEC Filings

May 28, 2026

US Earnings Financial Results SEC Filings — May 28, 2026

US Earnings Financial Results SEC Filings
← All United States digests